Proteomic characterization of non-small cell lung cancer (NSCLC): Discovery and validation of NSCLC protein signatures and signaling networks

被引：0
|
作者：
Wei, Yuhong [1 ]
Taylor, Paul [1 ]
Tong, Jiefei [1 ]
Strumpf, Dan [2 ]
Ignatchenko, Vladimir [2 ]
Nhu An Pham [2 ]
Thyparambil, Sheeno [3 ]
Tsao, Ming-Sound [2 ]
Kislinger, Thomas [2 ]
Moran, Michael F. [1 ]
机构：
[1] Hosp Sick Children, Toronto, ON M5G 1X8, Canada
[2] Ontario Canc Inst, Toronto, ON M4X 1K9, Canada
[3] Express Pathol Inc, Rockville, MD USA
来源：
CANCER RESEARCH | 2011年 / 71卷
关键词：
D O I：
10.1158/1538-7445.AM2011-5097
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
5097
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Sequential chemotherapy in non-small cell lung cancer (NSCLC)
    不详
    ANTICANCER RESEARCH, 2005, 25 (6D) : 4831 - 4832
  • [32] Induction therapy for non-small cell lung cancer (NSCLC)
    Nakamura, H
    Furukawa, K
    Ikeda, N
    Shibuya, H
    Tanaka, K
    Okunaka, T
    Hirano, T
    Sakai, M
    Saito, M
    Konaka, C
    Kato, H
    XXX WORLD CONGRESS OF THE INTERNATIONAL COLLEGE OF SURGEONS, VOLS 1-2, 1996, : 1029 - 1033
  • [33] Personalized Therapy of Non-small Cell Lung Cancer (NSCLC)
    Gadgeel, Shirish M.
    LUNG CANCER AND PERSONALIZED MEDICINE: NOVEL THERAPIES AND CLINICAL MANAGEMENT, 2016, 890 : 203 - 222
  • [34] PET/MRI in Non-Small Cell Lung Cancer (NSCLC)
    Alorfi, Fawziah
    Bomanji, Jamshed
    Bertoletti, Linda
    Fraioli, Francesco
    SEMINARS IN NUCLEAR MEDICINE, 2025, 55 (02)
  • [35] Characterization of 164 patients with NRAS mutated non-small cell lung cancer (NSCLC)
    Dehem, Agathe
    Mazieres, Julien
    Chour, Ali
    Guisier, Florian
    Ferreira, Marion
    Boussageon, Maxime
    Girard, Nicolas
    Moro-Sibilot, Denis
    Cadranel, Jacques
    Zalcmanl, Gerard
    Ricordel, Charles
    Wislez, Marie
    Munck, Camille
    Poulet, Claire
    Gauvain, Clement
    Descarpentries, Clotilde
    Wasielewski, Eric
    Cortot, Alexis B.
    Baldacci, Simon
    LUNG CANCER, 2023, 186
  • [36] Tumor microcirculation based biomarker discovery strategy for non-small cell lung cancer (NSCLC)
    Breiva, D.
    Tracums, I.
    Jaunalksne, I.
    Krievins, D.
    Bistrova, A.
    Spaks, A.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S62 - S62
  • [37] Tissue microarray for protein profiling in non-small cell lung cancer (NSCLC): Discovery and validation of novel biomarkers for prediction of recurrence and treatment response
    Robert, F
    Robert, S
    deShazo, M
    Reddy, V
    Diasio, R
    Ezzeldin, H
    Carey, D
    Chen, D
    Schreeder, M
    Ross, D
    LUNG CANCER, 2005, 49 : S72 - S73
  • [38] Characterization of cancer stem cell and immune microenvironment interactions in non-small cell lung cancer (NSCLC)
    Torres, S.
    Sirera, R.
    Aguilar, C.
    Calabuig Farinas, S.
    Mosqueda, M.
    Herreros-Pomares, A.
    Escorihuela, E.
    Garcia del Olmo, E.
    Jantus-Lewintre, E.
    Camps Herrero, C.
    ANNALS OF ONCOLOGY, 2017, 28
  • [39] Immuntherapie des nichtkleinzelligen Lungenkarzinoms (NSCLC)Immunotherapy for non-small cell lung cancer (NSCLC)
    Nikolaj Frost
    Martin Reck
    Die Innere Medizin, 2022, 63 (7) : 709 - 716
  • [40] DELINEATION OF SPATIAL TISSUE SIGNATURES OF IMMUNOTHERAPY RESPONSE GROUPS IN NON-SMALL CELL LUNG CANCER (NSCLC)
    Kulasinghe, Arutha
    Monkman, James
    Kim, Honesty
    Mayer, Aaron
    Mehdi, Ahmed
    Cumberbatch, Marie
    Bhagat, Milan
    Schneider, Fabian
    Thaagard, Jeppe
    Mansfield, James
    Ladwa, Rahul
    Mueller, Scott
    Adams, Mark
    O'byrne, Kenneth
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 : A130 - A130
12345